Evidence map›Paper›PMID 33509076›Full record

Observational studyBMC cardiovascular disorders2021

The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.

Song-Jian He, Jian-Xin Weng, Hai-Jun Chen, Hua-Qiu Li, Wen-Qin Guo, Qian Cao, Shuai Xu, Hong-Bing Yan, Chang-Nong Peng

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Song-Jian He *Department of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Jian-Xin Weng *Department of Coronary Heart Disease, Peking University Shenzhen Hospital, 1120 Lianhua St, Futian District, Shenzhen, 518000, China.
Hai-Jun ChenDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Hua-Qiu LiDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Wen-Qin GuoDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Qian CaoDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Shuai XuDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Hong-Bing YanDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China.
Chang-Nong PengDepartment of Coronary Heart Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Langshan Road 12, Shenzhen, 518000, China. 819650730@qq.com.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe model for end-stage liver disease excluding international normalized ratio (MELD-XI) is a simple score for risk assessment. However, the prognostic role of MELD-XI and its additional value to current risk assessment in elderly patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) is uncertain.

methodsIn all, 1029 elderly patients with STEMI undergoing PCI were consecutively included and classified into three groups according to the TIMI risk score: low-risk (≤ 3, n = 251); moderate-risk (4-6, n = 509); and high-risk (≥ 7, n = 269) groups. Multivariate analysis was performed to identify risk factors for adverse events.

resultsThe overall in-hospital mortality was 5.3% and was significantly higher in the high-risk group (1.2% vs. 3.3% vs. 13.0%, p < 0.001). The optimal cut-off of the TIMI risk score and MELD-XI for in-hospital death was 7 and 13, respectively. MELD-XI was associated with in-hospital (adjusted odds ratio = 1.09, 95% CI = 1.04-1.14, p = 0.001) and one-year (adjusted hazard ratio = 1.05, 95% CI = 1.01-1.08, p = 0.005) mortality independently of the TIMI risk score. Combining TIMI risk score and MELD-XI exhibited better predictive power for in-hospital death than TIMI risk score (area under the curve [AUC] = 0.810 vs. 0.753, p = 0.008) or MELD-XI alone (AUC = 0.810 vs. 0.750, p = 0.018). Patients with TIMI risk score ≥ 7 and MELD-XI ≥ 13 had the worst prognosis.

conclusionMELD-XI could be considered as a risk-stratified tool for elderly patients with STEMI undergoing PCI. It had an additive prognostic value to TIMI risk score.

Indexed as

Clinical Decision RulesPercutaneous Coronary InterventionAgedAge FactorsClinical Decision-MakingEnd Stage Liver DiseaseFemaleHospital MortalityHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexMELD-XIPercutaneous coronary interventionST-segment elevation myocardial infarctionTIMI risk score

Identifiers

PMID33509076
PMCPMC7842073
OpenAlexW3125833178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.